slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 4,681-4,710
Pages 350
Rows per page 30
Slide type
4,681-4,710 of 10,471
28
Includes a testimonial/quote from a partner at the bottom.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
34
The slide outlines the methodology and status of a clinical trial.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
35
The slide uses clinical trial data to justify the pivot to a topical delivery mechanism.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
36
Includes both tabular pharmacokinetic data and a line chart showing plasma concentration over time.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
42
The slide details results from two completed studies (Phase 1 and Phase 1/2) for a hormone therapy product.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
45
The slide presents clinical trial data comparing baseline to month 3 outcomes and systemic absorption levels.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
17
The slide presents visual evidence (photos of tumors) alongside quantitative bar charts showing efficacy metrics.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
26
The chart shows a significant drop in viral load after day 14, maintaining a low level from day 145 onwards.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
19
The slide uses a split layout with status bullets on the left and photographic evidence of the facility on the right.Faraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations 1 hit
13
Includes PET scan imagery showing metabolic response in a patient.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
14
The table displays patient-level outcomes including response type, prior therapy history, and number of prior lines of therapy.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
15
Data presented at AACR 2021. Shows two separate mouse model experiments (H1975-OsiR and H1975).Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
18
The slide uses a Kaplan-Meier survival plot to illustrate therapeutic efficacy.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
20
The slide presents two charts: a line chart showing tumor progression over time and a bar chart showing tumor intensity at week 4.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
13
Includes medical imaging showing metabolic response in a patient.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
14
The table displays individual patient outcomes including tumor regression and disease stability.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
15
The slide presents two line charts comparing tumor volume over time across different treatment groups. It includes statistical significance markers (p-values) for the combination therapies.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
18
The slide uses a Kaplan-Meier survival plot to demonstrate efficacy. The visual comparison of lung tissue provides qualitative support for the quantitative survival data.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
20
The slide uses TUSC2 as the synonym for REQORSA in the charts. Data shows statistical significance (p-values) for the triple combination.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
24
The slide uses a vertical process flow diagram to illustrate strategic focus areas.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
31
The slide presents a Glucose Tolerance Test line chart and a bar chart for beta cell mass, demonstrating the efficacy of the AAV8-PM gene therapy.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
32
Includes a line chart showing blood glucose over time and a bar chart showing beta cell mass comparison.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
33
The charts track insulin/carb ratios over time relative to a viral infusion event.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
42
The slide uses a two-column layout to contrast past progress with future goals.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action1 hit
08
The slide uses a callout bubble to emphasize the consistency of findings across all listed models.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
14
The slide uses a process-style arrow diagram to represent the sequence of Phase 1 study components.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
17
The slide presents clinical trial outcomes for a pharmaceutical asset.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
21
The slide uses a network graph to visualize gene interactions, categorized by color-coded functional groups.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
06
Includes pro-forma data and forward-looking projections for 2022-2025.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
14
The slide uses a combination of bar charts for group/brand growth and big-number metrics for specific segment growth, accompanied by product imagery.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations Beat · Solution1 hit